Editorial

sorafenib toxicity, a biomarker of effect?

K. E. Clare, M. H. Miller, J. F. Dillon (Lead / Corresponding author)

Research output: Contribution to journalEditorial

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1469-1470
Number of pages2
JournalAlimentary Pharmacology & Therapeutics
Volume45
Issue number11
Early online date5 May 2017
DOIs
Publication statusPublished - Jun 2017

Keywords

  • Editorial

Cite this

Clare, K. E. ; Miller, M. H. ; Dillon, J. F. / Editorial : sorafenib toxicity, a biomarker of effect?. In: Alimentary Pharmacology & Therapeutics. 2017 ; Vol. 45, No. 11. pp. 1469-1470.
@article{13b96f64cd024e1bb6d241f6519d2461,
title = "Editorial: sorafenib toxicity, a biomarker of effect?",
keywords = "Editorial",
author = "Clare, {K. E.} and Miller, {M. H.} and Dillon, {J. F.}",
note = "Declaration of funding interests: None",
year = "2017",
month = "6",
doi = "10.1111/apt.14033",
language = "English",
volume = "45",
pages = "1469--1470",
journal = "Alimentary Pharmacology & Therapeutics",
issn = "0269-2813",
publisher = "Wiley",
number = "11",

}

Editorial : sorafenib toxicity, a biomarker of effect? / Clare, K. E.; Miller, M. H.; Dillon, J. F. (Lead / Corresponding author).

In: Alimentary Pharmacology & Therapeutics, Vol. 45, No. 11, 06.2017, p. 1469-1470.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Editorial

T2 - sorafenib toxicity, a biomarker of effect?

AU - Clare, K. E.

AU - Miller, M. H.

AU - Dillon, J. F.

N1 - Declaration of funding interests: None

PY - 2017/6

Y1 - 2017/6

KW - Editorial

U2 - 10.1111/apt.14033

DO - 10.1111/apt.14033

M3 - Editorial

VL - 45

SP - 1469

EP - 1470

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

SN - 0269-2813

IS - 11

ER -